PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Bosutinib In Subjects With Renal Impairment
- Conditions
- Renal Disease, End-StageRenal Insufficiency, ChronicRenal Insufficiency, Acute
- Interventions
- First Posted Date
- 2010-11-03
- Last Posted Date
- 2012-07-03
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 34
- Registration Number
- NCT01233882
- Locations
- 🇺🇸
Pfizer Investigational Site, Saint Paul, Minnesota, United States
A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy
- Conditions
- Lymphoma, Non-Hodgkin
- Interventions
- First Posted Date
- 2010-11-02
- Last Posted Date
- 2019-01-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 338
- Registration Number
- NCT01232556
- Locations
- 🇺🇸
Ronald Reagan UCLA Medical Center Drug Information Center Department of Pharmaceutical Services, Los Angeles, California, United States
🇺🇸University of Kansas Cancer Center and Medical Pavilion, Westwood, Kansas, United States
🇨🇦Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects
- First Posted Date
- 2010-10-29
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 75
- Registration Number
- NCT01230385
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan)
- First Posted Date
- 2010-10-28
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 3
- Registration Number
- NCT01230177
- Locations
- 🇯🇵
Taihaku Sakura Hospital, Sendai, Miyagi, Japan
Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex)
- Conditions
- Dupuytren's Contracture
- Interventions
- Drug: Xiapex
- First Posted Date
- 2010-10-27
- Last Posted Date
- 2014-03-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 254
- Registration Number
- NCT01229436
- Locations
- 🇬🇧
Pfizer Investigational Site, Southampton, United Kingdom
Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients
- First Posted Date
- 2010-10-25
- Last Posted Date
- 2013-04-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 476
- Registration Number
- NCT01227395
Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease
- Conditions
- Alzheimer's Disease
- Interventions
- Other: Placebo- Phosphate buffered saline (PBS)Biological: ACC-001 10 μg/ QS-21 50 μgBiological: ACC-001 3 μg/ QS-21 50 μg
- First Posted Date
- 2010-10-25
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 63
- Registration Number
- NCT01227564
- Locations
- 🇺🇸
Banner Lakes Imaging Center, Sun City, Arizona, United States
🇺🇸Universal Medical Center, Tucson, Arizona, United States
🇺🇸Internal Medicine Associates of Lee County, MD, PA, Fort Myers, Florida, United States
Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes
- First Posted Date
- 2010-10-22
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 24
- Registration Number
- NCT01226797
- Locations
- 🇰🇷
Severance Hospital, Yonsei University College of Medicine, Division of Gastroenterology, Seoul, Korea, Republic of
🇮🇳Institute of Liver & Biliary Sciences, New Delhi, India
🇸🇬Singapore General Hospital, Singapore, Singapore
A Study In Healthy Volunteers To Assess The Safety, Tolerability, And Relative Oral Bioavailability Of Three Formulations Of PH-797804
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2010-10-22
- Last Posted Date
- 2011-03-10
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 18
- Registration Number
- NCT01226693
- Locations
- 🇸🇬
Pfizer Investigational Site, Singapore, Singapore
A Study Of Tasocitinib In Dry Eye Subjects
- Conditions
- Keratoconjunctivitis Sicca
- Interventions
- First Posted Date
- 2010-10-22
- Last Posted Date
- 2018-11-29
- Lead Sponsor
- Pfizer
- Registration Number
- NCT01226680